Adial Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 164.13 K | $58.02 K | 138.38% | 1.55% |
| VANGUARD GROUP INC | 11/07/2025 | 156.02 K | $55.23 K | 1,085.68% | 1.47% |
| CITADEL ADVISORS LLC | 11/14/2025 | 143.79 K | $50.83 K | 100.00% | 1.35% |
| MANCHESTER CAPITAL MANAGEMENT LLC | 11/14/2025 | 48.10 K | $17.00 K | 0.00% | 0.45% |
| BLACKROCK, INC. | 11/12/2025 | 27.77 K | $9.82 K | 0.00% | 0.26% |
| UBS GROUP AG | 11/13/2025 | 18.76 K | $6.62 K | 51.34% | 0.18% |
| TWO SIGMA SECURITIES, LLC | 11/14/2025 | 12.84 K | $4.54 K | 100.00% | 0.12% |
| JANE STREET GROUP, LLC | 11/14/2025 | 12.34 K | $4.36 K | -50.36% | 0.12% |
| HRT FINANCIAL LP | 11/14/2025 | 11.19 K | $3.00 K | -41.38% | 0.11% |
| PRIVATE MANAGEMENT GROUP INC | 11/13/2025 | 10.00 K | $3.54 K | 100.00% | 0.09% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 1.40 K | $493 | 5.92% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 1.37 K | $484 | -3.45% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 182 | $64 | 149.32% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 160 | $57 | 0.00% | 0.00% |
| ABOUND WEALTH MANAGEMENT | 10/10/2025 | 27 | $10 | 0.00% | 0.00% |
| MORGAN STANLEY | 11/14/2025 | 9 | $3 | 0.00% | 0.00% |
| CITIGROUP INC | 11/10/2025 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| STONE HOUSE INVESTMENT MANAGEMENT, LLC | 10/27/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Adial Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 22 institutional investors and hedge funds held shares of Adial Pharmaceuticals, Inc.. The most heavily invested institutionals were:
GEODE CAPITAL MANAGEMENT, LLC: 164,127
VANGUARD GROUP INC: 156,024
CITADEL ADVISORS LLC: 143,791
Manchester Capital Management LLC: 48,097
BlackRock, Inc.: 27,770
UBS Group AG: 18,758
5.72% of Adial Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 651.75 K shares in the last 24 months. This purchase volume represents approximately $259.66 K in transactions.